Risk of chronic Q fever in patients with cardiac valvulopathy, seven years after a large epidemic in the Netherlands.

by Marit M A de Lange, Arko Scheepmaker, Wim van der Hoek, Monique Leclercq, Peter M Schneeberger
Published 2019-01-01

Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries.

by Ineke T Spruijt, Marit M A de Lange, Frederika Dijkstra, Gé A Donker, Wim van der Hoek
Published 2016-01-01

High Coxiella burnetii Seroconversion Rate in Veterinary Students, the Netherlands, 2006–2010

by Marit M.A. de Lange, Wim van der Hoek, Peter M. Schneeberger, Arno Swart, Dick J.J. Heederik, Barbara Schimmer, Inge M. Wouters
Published 2020-12-01

Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.

by Maryam Darvishian, Frederika Dijkstra, Eva van Doorn, Maarten J Bijlsma, Gé A Donker, Marit M A de Lange, Laura M Cadenau, Eelko Hak, Adam Meijer
Published 2017-01-01

Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands

by Pieter T. de Boer, Marit M.A. de Lange, Cornelia C.H. Wielders, Frederika Dijkstra, Sonja E. van Roeden, Chantal P. Bleeker-Rovers, Jan Jelrik Oosterheert, Peter M. Schneeberger, Wim van der Hoek
Published 2020-02-01

Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands

by Liselotte van Asten, Carel N. Harmsen, Lenny Stoeldraijer, Don Klinkenberg, Anne C. Teirlinck, Marit M.A. de Lange, Adam Meijer, Jan van de Kassteele, Arianne B. van Gageldonk-Lafeber, Susan van den Hof, Wim van der Hoek
Published 2021-02-01